FDA Inspection 1215341 — Cerovene Inc.
The FDA completed an inspection of Cerovene Inc. on August 1, 2023 in Valley Cottage, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 1, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Valley Cottage, NY (United States)